Kolexia
Kiakouama Lize
Pneumologie
Hôpital La Croix-Rousse
Lyon, France
62 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Hypertension pulmonaire Hypertension artérielle Broncho-pneumopathie chronique obstructive Maladies pulmonaires Carcinome pulmonaire à petites cellules Pneumopathies interstitielles Infections à VIH

Industries

GSK
7 collaboration(s)
Dernière en 2022
Sanofi
6 collaboration(s)
Dernière en 2023
MSD
3 collaboration(s)
Dernière en 2023
BMS
2 collaboration(s)
Dernière en 2020

Dernières activités

SMALLHAN: Assessment of Tobacco Smoking and Alcohol Drinking and Treatment Outcomes Among Patients With Lung or Head and Neck Cancer
Essai Clinique (Hospices Civils de Lyon)   16 février 2024
MONITOR: Impact of Telemonitoring for the Management of Side Effects in Patients With Melanoma, Lung or Renal Cancer, Treated With Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy
Essai Clinique (Hospices Civils de Lyon)   11 décembre 2023
ILYAD: Pilot Study on Lung Cancer Screening Implementation Among Employees at Lyon Hospital
Essai Clinique (Hospices Civils de Lyon)   26 septembre 2023
CIRCAN MAP: MAster Protocol Studying the Impact of Blood Biopsy on Screening, Diagnosis, Diagnostic and Follow-up of Solid Cancer in Adult
Essai Clinique (Hospices Civils de Lyon)   21 juillet 2023
A challenging case of thoracic empyema caused by spp.
Respiratory medicine case reports   15 décembre 2021
IMMUCARE-BASE: A Clinical and Biological Prospective Database of Patients Treated With Anticancer Immunotherapy and Follow up of Their Immune-related Adverse Events irAE
Essai Clinique (Hospices Civils de Lyon)   26 juillet 2021
ONCOPRO: Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Essai Clinique (Hospices Civils de Lyon)   12 juillet 2021
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial.
Lung cancer (Amsterdam, Netherlands)   28 mai 2021
Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes.
Cancers   14 mai 2021
Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA).
Lung cancer (Amsterdam, Netherlands)   13 mai 2021